In vitro activities of 22 beta-lactam antibiotics against penicillin-resistant and penicillin-susceptible viridans group streptococci isolated from blood.
about
Guidelines for preventing infectious complications among hematopoietic cell transplantation recipients: a global perspectiveFluoroquinolone resistance mutations in the parC, parE, and gyrA genes of clinical isolates of viridans group streptococciE test versus agar dilution for antimicrobial susceptibility testing of viridans group streptococci.Molecular relationships and antimicrobial susceptibilities of viridans group streptococci isolated from blood of neutropenic cancer patients.Evaluation of the PASCO strep plus broth microdilution antimicrobial susceptibility panels for testing Streptococcus pneumoniae and other Streptococcal species.DNA relatedness, phenotypic characteristics, and antimicrobial susceptibilities of Globicatella sanguinis strains.In vitro activities of fluoroquinolones against antibiotic-resistant blood culture isolates of viridans group streptococci from across Canada.Antimicrobial susceptibilities and clinical sources of Facklamia speciesIn vitro activities of the new ketolide HMR 3647 (telithromycin) in comparison with those of eight other antibiotics against viridans group Streptococci isolated from blood of neutropenic patients with cancerClinical characteristics and significance of Streptococcus salivarius bacteremia and Streptococcus bovis bacteremia: a prospective 16-year study.Cefditoren, a new aminothiazolyl cephalosporin.Species-specific difference in antimicrobial susceptibility among viridans group streptococci.Viridans group streptococci are donors in horizontal transfer of topoisomerase IV genes to Streptococcus pneumoniaeIn vitro activities of eight macrolide antibiotics and RP-59500 (quinupristin-dalfopristin) against viridans group streptococci isolated from blood of neutropenic cancer patients.High incidence of erythromycin-resistant streptococci in Taiwan.Drug efflux and parC mutations are involved in fluoroquinolone resistance in viridans group streptococci.Horizontal transfer of parC and gyrA in fluoroquinolone-resistant clinical isolates of Streptococcus pneumoniae.Cefepime versus ceftazidime as empiric therapy for fever in neutropenic patients with cancer.Prevalence of β-hemolytic groups C and F streptococci in patients with acute pharyngitis.Macrolide and clindamycin resistance in Streptococcus milleri group isolates from the airways of cystic fibrosis patients.Development and validation of a clinical model to predict the presence of β-lactam resistance in viridans group streptococci causing bacteremia in neutropenic cancer patients.Evolution, incidence, and susceptibility of bacterial bloodstream isolates from 519 bone marrow transplant patients.Gradient plate method to induce Streptococcus pyogenes resistance.In vitro activity of moxifloxacin compared to other antimicrobials against streptococci isolated from iatrogenic oral bacteremia in Spain.Early bacteremia in pediatric hematopoietic stem cell transplant patients on oral antibiotic prophylaxis.Serious complications of bacteremia caused by Viridans streptococci in neutropenic patients with cancer.
P2860
Q28388806-87A76D51-7C01-4BC8-9484-E137114A6C3FQ33700561-D5E14699-D952-411F-AEC2-6E6BAF3272E7Q33957980-9FC186FA-6257-49EE-B533-4E0CA96B1FEDQ33960926-B67DA66C-A6A4-46CC-99A2-07B526DA61F5Q33966759-2DBC6664-037D-4C8A-A475-67926405B16EQ33974031-7E0B23E5-28EE-46B5-8D74-E8D75EADF3C2Q33977709-1EF8591C-807A-4EF2-B72B-48BE18121E4DQ33980225-66583BC5-0846-49FA-B8F9-29217B4C1C3EQ33981500-79728780-DB7E-40D5-A0B2-AFBA915C4332Q34557760-3ABF2F40-6179-4C10-9A82-E0C7F23DE30BQ34975678-0FC0E777-3749-401B-A799-3CB259561218Q35088472-0CE4E37C-393D-45A7-B427-CABCF8014893Q35102420-F5F0004B-9813-47E3-9BF1-3E90603C96E0Q35126797-8CE9F18A-DD79-49EB-8198-74EB5DC5048CQ35135285-7CF0558F-70A0-4146-85B5-EC0B76D73469Q39472017-A4A17627-769B-4F44-BFBF-8BB2DE4CE9A3Q39473366-EAE836CF-EB92-4E02-8451-089852CBE4D0Q40615385-0A6869C1-5904-4ACC-BEFB-6B7E23B3E446Q41906805-34361E31-BDDA-4B1A-856E-D7C92C35A8AAQ42023933-BA7AE16C-0118-4C75-9E17-45B4B10670C4Q42218307-E1A2D65B-9FF5-4569-83ED-68F37BAFAADFQ43723782-9FA42490-0389-475E-AE4C-EBB134C02FEFQ43869393-C1E4559A-9364-4603-A34D-9B2198C34945Q44645217-62C1B875-63E3-4987-ADFF-754875946B20Q45184235-CD842ADC-54A1-43B5-B828-B5EBB994A96EQ54030467-D77F27E2-1B26-43A8-9FBF-3C49181881DB
P2860
In vitro activities of 22 beta-lactam antibiotics against penicillin-resistant and penicillin-susceptible viridans group streptococci isolated from blood.
description
1995 nî lūn-bûn
@nan
1995 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
1995 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
1995年の論文
@ja
1995年論文
@yue
1995年論文
@zh-hant
1995年論文
@zh-hk
1995年論文
@zh-mo
1995年論文
@zh-tw
1995年论文
@wuu
name
In vitro activities of 22 beta ...... eptococci isolated from blood.
@ast
In vitro activities of 22 beta ...... eptococci isolated from blood.
@en
type
label
In vitro activities of 22 beta ...... eptococci isolated from blood.
@ast
In vitro activities of 22 beta ...... eptococci isolated from blood.
@en
prefLabel
In vitro activities of 22 beta ...... eptococci isolated from blood.
@ast
In vitro activities of 22 beta ...... eptococci isolated from blood.
@en
P2093
P2860
P356
P1476
In vitro activities of 22 beta ...... eptococci isolated from blood.
@en
P2093
Benitez MA
Carratala J
Pallares R
P2860
P304
P356
10.1128/AAC.39.10.2243
P407
P577
1995-10-01T00:00:00Z